Circulating blasts following chemotherapy in pediatric patients: Implications for complete remission definition in acute leukemia

Mihaela Onciu; Elihu Estey; Francis J. Giles

doi:10.1080/10245330310001604737

Circulating blasts following chemotherapy in pediatric patients: Implications for complete remission definition in acute leukemia

Mihaela Onciu, Elihu Estey, Francis J. Giles^*

^*Corresponding author for this work

Medicine, Hematology Oncology Division

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

We assessed the incidence of circulating blasts occurring post-chemotherapy in 1000 consecutive pediatric blood samples. Blasts with myeloid morphology (<1-3%) were present in post-chemotherapy samples in 19 of 294 (6.4%) patients with acute leukemia in remission and in 11 of 361 (3.4%) patients with solid tumors, non-Hodgkin or Hodgkin lymphoma, and were associated with ANC > 1.5 × 10⁹/l in 13 of 30 (43%) samples, and platelets > 100 × 10⁹/l in 25 of 30 (83%) samples. Our findings suggest that the absence of circulating blasts may not be a prerequisite for remission in acute myeloid leukemia (AML).

Original language	English (US)
Pages (from-to)	295-301
Number of pages	7
Journal	Hematology
Volume	8
Issue number	5
DOIs	https://doi.org/10.1080/10245330310001604737
State	Published - Oct 2003

Keywords

Acute leukemia
Blasts
Chemotherapy
Peripheral blood
Remission

ASJC Scopus subject areas

Hematology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1080/10245330310001604737

Cite this

@article{4a7b193f62854a878ebcea7f998d8a34,

title = "Circulating blasts following chemotherapy in pediatric patients: Implications for complete remission definition in acute leukemia",

abstract = "We assessed the incidence of circulating blasts occurring post-chemotherapy in 1000 consecutive pediatric blood samples. Blasts with myeloid morphology (<1-3\%) were present in post-chemotherapy samples in 19 of 294 (6.4\%) patients with acute leukemia in remission and in 11 of 361 (3.4\%) patients with solid tumors, non-Hodgkin or Hodgkin lymphoma, and were associated with ANC > 1.5 × 109/l in 13 of 30 (43\%) samples, and platelets > 100 × 109/l in 25 of 30 (83\%) samples. Our findings suggest that the absence of circulating blasts may not be a prerequisite for remission in acute myeloid leukemia (AML).",

keywords = "Acute leukemia, Blasts, Chemotherapy, Peripheral blood, Remission",

author = "Mihaela Onciu and Elihu Estey and Giles, \{Francis J.\}",

year = "2003",

month = oct,

doi = "10.1080/10245330310001604737",

language = "English (US)",

volume = "8",

pages = "295--301",

journal = "Hematology",

issn = "1024-5332",

publisher = "Taylor and Francis Ltd.",

number = "5",

}

TY - JOUR

T1 - Circulating blasts following chemotherapy in pediatric patients

T2 - Implications for complete remission definition in acute leukemia

AU - Onciu, Mihaela

AU - Estey, Elihu

AU - Giles, Francis J.

PY - 2003/10

Y1 - 2003/10

N2 - We assessed the incidence of circulating blasts occurring post-chemotherapy in 1000 consecutive pediatric blood samples. Blasts with myeloid morphology (<1-3%) were present in post-chemotherapy samples in 19 of 294 (6.4%) patients with acute leukemia in remission and in 11 of 361 (3.4%) patients with solid tumors, non-Hodgkin or Hodgkin lymphoma, and were associated with ANC > 1.5 × 109/l in 13 of 30 (43%) samples, and platelets > 100 × 109/l in 25 of 30 (83%) samples. Our findings suggest that the absence of circulating blasts may not be a prerequisite for remission in acute myeloid leukemia (AML).

AB - We assessed the incidence of circulating blasts occurring post-chemotherapy in 1000 consecutive pediatric blood samples. Blasts with myeloid morphology (<1-3%) were present in post-chemotherapy samples in 19 of 294 (6.4%) patients with acute leukemia in remission and in 11 of 361 (3.4%) patients with solid tumors, non-Hodgkin or Hodgkin lymphoma, and were associated with ANC > 1.5 × 109/l in 13 of 30 (43%) samples, and platelets > 100 × 109/l in 25 of 30 (83%) samples. Our findings suggest that the absence of circulating blasts may not be a prerequisite for remission in acute myeloid leukemia (AML).

KW - Acute leukemia

KW - Blasts

KW - Chemotherapy

KW - Peripheral blood

KW - Remission

UR - http://www.scopus.com/inward/record.url?scp=0142180058&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0142180058&partnerID=8YFLogxK

U2 - 10.1080/10245330310001604737

DO - 10.1080/10245330310001604737

M3 - Article

C2 - 14530171

AN - SCOPUS:0142180058

SN - 1024-5332

VL - 8

SP - 295

EP - 301

JO - Hematology

JF - Hematology

IS - 5

ER -

Circulating blasts following chemotherapy in pediatric patients: Implications for complete remission definition in acute leukemia

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this